The acetic acid and phenyl-p-benzoquinone are easy and fast screening models to access the activity of novel candidates as analgesic drugs and their mechanisms. These models induce a characteristic and quantifiable overt pain-like behavior described as writhing response or abdominal contortions. The knowledge of the mechanisms involved in the chosen model is a crucial step forward demonstrating the mechanisms that the candidate drug would inhibit because the mechanisms triggered in that model will be addressed. Herein, it was investigated the role of spinal mitogen-activated protein (MAP) kinases ERK (extracellular signalregulated kinase), JNK (Jun N-terminal Kinase) and p38, PI 3 K (phosphatidylinositol 3-kinase) and microglia in the writhing response induced by acetic acid and phenyl-p-benzoquinone, and flinch induced by formalin in mice. Acetic acid and phenyl-p-benzoquinone induced significant writhing response over 20 min. The nociceptive response in these models were significantly and in a dose-dependent manner reduced by intrathecal pre-treatment with ERK (PD98059), JNK (SB600125), p38 (SB202190) or PI 3 K (wortmannin) inhibitors. Furthermore, the co-treatment with MAP kinase and PI 3 K inhibitors, at doses that were ineffective as single treatment, significantly inhibited acetic acid-and phenyl-p-benzoquinone-induced nociception. The treatment with microglia inhibitors minocycline and fluorocitrate also diminished the nociceptive response. Similar results were obtained in the formalin test. Concluding, MAP kinases and PI 3 K are important spinal signaling kinases in acetic acid and phenyl-p-benzoquinone models of overt pain-like behavior and there is also activation of spinal microglia indicating that it is also important to determine whether drugs tested in these models also modulate such spinal mechanisms.
Introduction
The animal models evaluate two main symptoms of pain: i) hyperalgesia and allodynia or ii) overt nociception/overt pain-like behavior. Hyperalgesia is defined as an increase of pain sensation caused by a stimulus that normally induces pain and allodynia as pain due to a stimulus that does not normally provoke pain. Both result from the sensitization of nociceptors in which, for instance, inflammatory mediators activate second messenger pathways such as cyclic AMP, protein kinase A and protein kinase C with subsequent phosphorylation of the voltage-dependent sodium channels and the inhibition of the voltage-dependent potassium channels resulting in the lowering of the nociceptor threshold and increasing neuronal membrane excitability (Verri et al., 2006) . Hyperalgesia can be elicited in sensitized tissues by mechanical (Ferreira et al., 1978; Verri et al., 2008a) and thermal (Hargreaves et al., 1988) stimuli.
In overt nociception/overt pain-like behavior, an inflammatory stimulus induces a declared behavior such as paw flinch or licking and abdominal contortions (writhing) without further mechanical or thermal external stimuli. This declared behavior occurs because the overt nociceptive stimuli activate or induce fast production of endogenous mediators that activate the nociceptors. These stimuli are in general chemical (phenyl-p-benzoquinone-PBQ, acetic acid, formalin) but may also be biological (zymosan) (Collier et al., 1968; Dubuisson and Dennis, 1977; Verri et al., 2006 Verri et al., , 2008b .
The writhing response induced by PBQ and acetic acid are widely used models because they are easy to learn, replicable, fast to perform, and there is no need of special equipments (Verri et al., 2006) . Pharmacology, Biochemistry and Behavior 101 (2012) [320] [321] [322] [323] [324] [325] [326] [327] [328] In the acetic acid model, it was demonstrated that cytokines such as TNFα (tumor necrosis factor α), IL (Interleukin)-1β and chemokines act in synergy to induce the writhing response. These cytokines act in synergy since the injection of a pool of cytokines (TNFα, IL-1β and chemokine) rather than the injection of an isolated cytokine induces writhing response while inhibiting one of these cytokines diminishes the acetic acid-induced writhing response. However, the magnitude/number of writhing induced by injecting a pool of cytokines (TNFα, IL-1β and CXCL1 chemokine) is much lower compared to that induced in the acetic acid (Ribeiro et al., 2000) suggesting the participation of other nociceptive pathways. In fact, cyclooxigenase products (Ballou et al., 2000) and cysteinyl leukotrienes (Jain et al., 2001 ) also contribute to nociception in this model. The writhing response in the acetic acid model is reduced by treatment with opiods, cyclooxigenase inhibitors, and a variety of natural products (Valerio et al., 2007; Verri et al., 2008b ). The PBQ model presents a similar pharmacological profile although there are some differences in the mechanisms. For instance, the PBQ but not the acetic acid writhing depends on cytokines such as IL-18 and interferon (IFN)-γ, and endothelin-1 (Verri et al., 2008b) . It remains to be determined whether these peripheral mechanistic differences result in differences in spinal or supra spinal mechanisms.
Similar to the acetic acid model, there is also participation of TNFα, IL-1β and CXCL1 in the second phase of the formalin test (Chichorro et al., 2004) . Nevertheless, there are some other important mechanisms in the formalin test such as dorsal root ganglia activation of the mitogen-activated protein (MAP) kinase ERK (extracellular signal-regulated kinases) (Alter et al., 2010) and spinal activation of PI 3 K (phosphatidylinositil 3-kinase) (Pezet et al., 2008) . In fact, evidence suggests spinal inhibition of pain processing as a successful strategy to reduce pain with reduced incidence of systemic side effect by targeting cellular activity (e.g. microglia, astrocytes and neurons), kinases and other molecules. In addition to formalin test, spinal inhibition of MAP kinases p38, JNK (Jun N-terminal Kinase) and ERK, and PI 3 K attenuate carrageenin-induced peripheral hyperalgesia (Svensson et al., 2003; Choi et al., 2010; Fitzsimmons et al., 2010) , cytokine (e.g. TNFα, G-CSF [granulocyte-colony stimulating factor])-induced mechanical hyperalgesia (Carvalho et al., 2011; Zhang et al., 2011) , and nerve lesion-induced neuropathic pain (Obata et al., 2004; Xu et al., 2007; Gao and Ji, 2010) . Thus, consistent data support that spinal inhibition of MAP kinases and PI 3 K reduce inflammatory and neuropathic pain. Therefore, investigating whether a potential analgesic drug presents inhibitory effects on spinal MAP kinases and PI 3 K is an important approach to determine its mechanisms. In this sense, the knowledge of the mechanisms involved in the nociception model and defining the nociception model is a crucial step of a study.
Cytokines such as TNFα and IL-1β mediate the writhing response (Ribeiro et al., 2000) and induce spinal or neuronal activation of MAP kinases and/or PI 3 K (Davis et al., 2006; Zhang et al., 2011) . However, it is not known whether acetic acid and PBQ induce overt pain-like behavior via spinal activation of p38, ERK and JNK, and/or PI 3 K or the participation of spinal microglia in writhing response. Therefore, it was evaluated the spinal mechanisms involved in acetic acid-and PBQ-induced writing response in mice focusing on the participation of MAP kinases, PI 3 K and microglia. Two models of writhing response were used to assess whether this response depends on similar spinal mechanisms despite some peripheral mechanistic differences. Furthermore, the formalin model was used for mechanistic comparison purposes.
Material and methods

Animals
The experiments were performed on male Swiss mice (20-25 g, Universidade Estadual de Londrina, Londrina, PR, Brazil) housed in standard clear plastic cages (six per cage) with free access to food and water. All behavioral testing was performed between 9:00 am and 5:00 pm in a temperature-controlled room. Animals' care and handling procedures were in accordance with the International Association for Study of Pain (IASP) guidelines and with the approval of the Ethics Committee of the Universidade Estadual de Londrina. All efforts were made to minimize the number of animals used and their suffering. It is noteworthy that different experimenters prepared the solutions, made the administrations and performed the evaluation of overt pain-like behavior.
Writhing response tests
The PBQ (Emele and Shanaman, 1967) -and acetic acid (Collier et al., 1968) -induced writhing models were performed as previously described at doses determined previously (Verri et al., 2008b; Valerio et al., 2009) . PBQ (diluted in DMSO 2%/saline; 1890 μg/kg), acetic acid (0.8% v/v, saline, 10 ml/kg) or vehicle was injected into the peritoneal cavities of mice. Each mouse was placed in a large glass cylinder and the intensity of nociceptive behavior was quantified by counting the total number of writhes (contraction of the abdominal muscle together with a stretching of hind limbs or rotation of the trunk) occurring between 0 and 20 min after stimulus injection. The intensity of the writhing response was expressed as the cumulative number of writhings at 2 min interval over 20 min or the total writhing over 20 min.
Formalin test
The number of paw flinches was determined between 0 and 30 min after intraplantar injection of 25 μL of formalin 1.5% as previously described (Valerio et al., 2009) . The period was divided in intervals of 5 min and clearly demonstrated the presence of the first and second phases, which are characteristic of the method.
Intrathecal (i.t.) drug administration
The i.t. injections were performed under light halothane anesthesia (1-2%). The dorsal fur of each mouse was shaved, the spinal column was arched, and a 29-gauge needle was directly inserted into the subarachnoid space, between the L4 and L5 vertebrae (Mestre et al., 1994) . Correct i.t. positioning of the needle tip was confirmed by manifestation of a characteristic tail flick response. A 5 μl volume containing the test agent (PD98059, SP600125, SB202190, wortmannin, minocycline or fluorocitrate) was slowly injected. Note that drugs delivered to the subarachnoidal space by i.t. injection can diffuse into the cerebrospinal fluid, which bathes the spinal cord, the dorsal roots, and part of dorsal root ganglion (Funez et al., 2008) .
Drugs
Drugs were obtained from the following sources: acetic acid and formalin from Mallinckrodt Baker, S.A (Mexico City, Mexico); phenyl-p-benzoquinone, minocycline (50 μg/intrathecal [i.t.]), fluorocitrate (1.6 μg/intrathecal [i.t.]), PD98059 (0.1-10 μg/intrathecal [i.t.]), SB202190 (0.1-10 μg/i.t.), SP600125 (0.1-10 μg/i.t.), and wortmannin (0.1-10 μg/i.t.) were obtained from Sigma-Aldrich (St. Louis, MO, USA). Acetic acid and formalin were dissolved in saline (NaCl 0.9%), PBQ, minocycline and fluorocitrate were dissolved in 2% DMSO in saline, and all other compounds were dissolved in 20% DMSO in saline.
Statistical analysis
Results are presented as means ± s.e.m. of measurements made on 6 mice in each group. Two-way analysis of variance (ANOVA) was used to compare the groups and doses at all times (curves). The analyzed factors were treatments, time and time versus treatment interaction. When there was a significant time versus treatment interaction, one-way ANOVA followed by Bonferroni's t-test was performed for each time. On the other hand, when the nociceptive responses were presented as total writhing within 20 min or at indicated time period, the differences between responses were evaluated by oneway ANOVA followed by Bonferroni's t-test. Statistical differences were considered to be significant at P b 0.05.
Results
Role of spinal ERK activation in acetic acid-, PBQ-and formalin-induced overt pain-like response
Mice were treated intrathecally (i.t.) with the MEK1/2 inhibitor (prevents ERK1/2 activation) PD98059 (1-10 μg or 0.1-10 μg) or vehicle (5 μl of 20% DMSO in saline) 30 min before intraperitoneal (i.p.) acetic acid (Fig. 1A) , PBQ (Fig. 1B) or intraplantar (i.pl.) formalin (Fig. 1C) stimulus. These dose ranges and vehicle concentration were chosen based on previous studies (Zhuang et al., 2004 (Zhuang et al., , 2005 Carvalho et al., 2011) . Acetic acid ( (Fig. 1B) . The dose of 3 μg of PD98059 reduced acetic acidinduced writhing between 6 and 14 min (Fig. 1A) , and PBQ-induced writhing between 6 and 8 min (Fig. 1B) . On the other hand, the dose of 10 μg of PD98059 significantly inhibited acetic acid-induced writhing response between 6 and 20 min compared to vehicle i.t. + acetic acid i.p. group (Fig. 1A) . In the PBQ model, there was significant inhibition of nociceptive behavior by PD98059 10 μg treatment between 6 and 20 min compared to vehicle i.t. + PBQ i.p. group and between 18 and 20 min compared to the lower dose of PD98059 tested (Fig. 1B) . In the formalin model, the dose of 0.1 of PD98059 did not significantly inhibit the nociceptive response (flinches). On the other hand, the dose of 1 μg of PD98059 inhibited the formalin-induced flinches at 5 and 25 min, and the dose of 10 μg of PD98059 significantly inhibited formalin-induced flinch response in all times evaluated (0-30 min) compared to vehicle i.t. + formalin (i.pl.) and compared to the lower dose of PD98059 tested (Fig. 1C) .
Role of spinal JNK in acetic acid-, PBQ-and formalin-induced overt-pain like response
Mice were treated i.t. with the JNK inhibitor SP600125 (1-10 μg or 0.1-10 μg) or vehicle (5 μl of 20% DMSO in saline) 30 min before i.p. acetic acid ( Fig. 2A) , PBQ (Fig. 2B) or formalin (Fig. 2C ) stimulus. These dose ranges and vehicle concentration were chosen based on previous studies (Doya et al., 2005; Carvalho et al., 2011) . Acetic acid ( Fig. 2A) , PBQ ( Fig. 2B ) and formalin ( Fig. 2C ) induced significant nociceptive behavior. There was a tendency of dose-dependent reduction of acetic acid ( Fig. 2A) , PBQ ( Fig. 2B ) and formalin ( Fig. 2C ) writhing response by SP600125 treatment. The doses of 1 and 3 μg of SP600125 did not significantly inhibit acetic acid-induced writhing response ( Fig. 2A) , and the dose of 10 μg of SP600125 significantly inhibited acetic acidinduced writhing response between 10-20 min compared to vehicle i.t.+ acetic acid i.p. group, and at 20 min compared to the lower dose of SP600125 ( Fig. 2A) . In the PBQ model, the doses of 1 and 3 μg of SP600125 did not affect the nociceptive behavior, except that the dose of 3 μg presented significant inhibition at 12 min. There was significant inhibition of nociceptive behavior by SP600125 treatment between 6 and 20 min compared to vehicle i.t. + acetic acid i.p. group (Fig. 2B ). The dose of 0.1 μg of SP600125 did not significantly inhibit formalininduced flinch response (Fig. 2C) , and the dose of 1 μg of SP600125 significantly inhibited formalin-induced flinch response between 25 and 30 min compared to vehicle i.t. + formalin i.p. group. The dose of 10 μg significantly inhibited formalin-induced flinch response in all times evaluated compared with vehicle i.t. + formalin (paw) and compared to the lower dose of SP600125 (Fig. 2C ).
Role of spinal p38 in acetic acid-, PBQ-and formalin-induced overt pain-like response
Mice were treated i.t. with the p38 inhibitor SB202190 (0.1-10 μg) or vehicle (5 μl of 20% DMSO in saline) 30 min before acetic acid (Fig. 3A) , PBQ (Fig. 3B) or formalin (Fig. 3C ) stimulus. These dose ranges and vehicle concentration were chosen based on previous studies (Chen et al., 2009; Carvalho et al., 2011) . Acetic acid (Fig. 3A) , PBQ ( Fig. 3B ) and formalin ( Fig. 3C ) induced significant nociceptive behavior. There was a tendency of reduction with the doses of 1 and 3 μg of SB202190, but it was not significant in the acetic acid model (Fig. 3A) . On the other hand, the acetic acid-induced writhing response was inhibited between 8 and 20 min by the dose of 10 μg of SB202190 compared to vehicle i.t. + acetic acid i.p. group (Fig. 3A) . The PBQ-induced writhing response was not significantly inhibited by 1 μg of SB202190. The dose of 3 μg of SB202190 inhibited PBQ-induced writhing response only at 20 min compared to vehicle i.t. + PBQ i.p. group (Fig. 3B) . Regarding the dose of 10 μg of SB202190 in the PBQ model, it inhibited the writhing response between 6 and 20 min, and at 14 min this inhibition was also significant compared to the lower dose of SB202190 tested (Fig. 3B) . The dose of 0.1 and 1 μg of SB202190 did not significantly inhibit formalininduced flinch response (Fig. 3C) . The dose of 10 μg significantly inhibited formalin-induced flinch response in all times evaluated compared with vehicle i.t.+ formalin (paw) and compared to the lower dose of SB202190 on times 5, 10, 15, 25, 30 min (Fig. 3C) . 30 min before acetic acid (Fig. 4A), PBQ (Fig. 4B) or formalin (Fig. 4C) stimulus. These dose ranges and vehicle concentration were chosen based on previous studies (Zhuang et al., 2004; Xu et al., 2007; Carvalho et al., 2011) . Acetic acid (Fig. 4A) and PBQ (Fig. 4B) i.p. injection induced significant nociceptive behavior starting at 6 min. The doses of 1 and 3 μg of wortmannin did not significantly inhibit acetic acid-induced writhing response (Fig. 4A) , and significant inhibition was observed with the dose of 10 μg of wortmannin between 8-20 min compared to vehicle i.t. + acetic acid i.p. group, and between 16 and 20 min compared to the lower dose of SB202190 (Fig. 4A) . The PBQ-induced writhing response was significantly reduced by 3 μg of wortmannin between 12 and 20 min and by 10 μg of wortmannin between 10 and 20 compared to vehicle i.t. + PBQ i.p. group. The dose of 10 μg of wortmannin also significantly inhibited PBQ nociception compared to the lower dose of wortmannin tested between 14 and 20 min (Fig. 4B) . The formalin-induced flinch response was significantly reduced by 0.1 μg of wortmannin at 5 min compared to vehicle i.t. + formalin i.p. group, and by 1 μg of wortmannin between 5 and 15 min compared to vehicle i.t. + formalin i.p. group and the lower dose of wortmannin tested. The dose of 10 μg of wortmannin significantly inhibited formalin-induced flinches in all time points compared to vehicle i.t. + formalin i.p. group and the lower dose of wortmannin tested (Fig. 4C) .
Combined Treatment with MAP kinases and PI 3 K inhibitors at doses that are ineffective as single treatment reduces acetic acid-, PBQ-and formalin-induced overt pain-like behavior response
Mice received single i.t. treatment with PD98059 (1 μg), SP600125 (1 μg), SB202190 (1 μg) or wortmannin (1 μg), or co-treatment with 1 μg of each MAP kinase inhibitors (PD98059, SP600125, SB202190) plus 1 μg of wortmannin in a single injection or vehicle (5 μl of 20% DMSO in saline) 30 min before acetic acid (Fig. 5A) or PBQ (Fig. 5B) stimulus. In the formalin model mice received single i.t. treatment with 0.1 μg of each drug or co-treatment in a single injection or vehicle (5 μl of 20% DMSO in saline) 30 min before formalin stimuli (Fig. 5C ). Acetic acid, PBQ and formalin injection nduced significant overtnociceptive response, which was unaffected by single treatment with PD98059, SP600125, SB202190 or wortmannin (Fig. 5A , B, C and D). On the other hand, the combination of those inhibitors at doses that were ineffective as single treatment significantly inhibited acetic acid-, PBQ-and formalin-induced overt pain-like behavior. This inhibition was also significant compared to the all single treatments (Fig. 5A , B, C and D).
Role of spinal microglia in acetic acid-, PBQ-and formalin-induced overt pain-like behavior
Mice received i.t. treatment with microglia inhibitors minocycline (50 μg-a broad spectrum tetracycline antibiotic, which inhibits microglia activity) (Maier et al., 2007) or fluorocitrate (1.6 μg-a specific inhibitor of microglia Krebs cycle) (Sun et al., 2008) or vehicle (5 μl of 2% DMSO in saline) 30 min before acetic acid (Fig. 6A) , PBQ (Fig. 6B) or formalin (Fig. 6C) stimulus. These dose ranges and vehicle concentration were chosen based on previous studies (Milligan et al., 2003; Ledeboer et al., 2005) . Acetic acid, PBQ and formalin injection induced significant overt pain-like behavior response (Fig. 6A, B and C). The treatment with minocycline and fluorocitrate significantly inhibit acetic acid-induced writhing response between 10 and 20 min compared to vehicle i.t. + acetic acid i.p. group (Fig. 6A) . The PBQinduced writhing response was significantly reduced by treatments between 8 and 20 min (Fig. 6B) . The formalin-induced writhing response was significantly reduced by treatments in all times tested except 15 min compared to vehicle i.t. + formalin i.pl. group (Fig. 6C ).
Discussion
Acetic acid-and phenyl-p-benzoquinone (PBQ)-induced writhing response are widely used models of overt nociception for screening and for determination of the mechanism of action of novel drugs. In the present study, it was demonstrated that acetic acid-and PBQinduced writhing response in mice depends on spinal activation of ERK, JNK, p38 and PI 3 K, and microglia. Similar results were observed in the formalin test raising the possibility that the cellular activation profile in the spinal cord could be similar among these models of overt pain-like behavior.
Inflammatory and neuropathic pain share similar mechanisms in the spinal cord such as activation of MAP kinases (ERK, JNK and p38) and PI 3 K (Svensson et al., 2003; Ji and Strichartz, 2004; Obata et al., 2004; Xu et al., 2007; Choi et al., 2010; Fitzsimmons et al., 2010; Gao and Ji, 2010; Zhang et al., 2011) .The activation of spinal MAP kinases and PI 3 K contribute to hyperalgesia by modulating ion channels, increasing the production of cytokines and other mediators and their receptors, and therefore, inducing the sensitization of nociceptors (Ji and Strichartz, 2004; Gao and Ji, 2010) . Interestingly, it is likely that dorsal root ganglia (DRG) and spinal activation of MAP kinases and PI 3 K also contributes to overt pain-like behavior in the formalin test (Pezet et al., 2008; Alter et al., 2010) suggesting that these kinases might also be involved in the activation of nociceptive neurons and not only in their plasticity and sensitization as demonstrated in models of inflammatory hyperalgesia and chronic neuropathic pain. In agreement, acute TNFα application rapidly enhances TTX (tetrodotoxin)-resistant sodium currents in isolated DRG neurons. This TNFα enhanced TTX-resistant sodium currents are blocked in TNFR1 (TNF receptor 1) deficient DRG neurons and by p38 inhibitor (SB202190). Therefore, acute TNFα/TNFR1-induced activation of p38 MAP kinase can rapidly increase TTX-resistant sodium currents in DRG neurons resulting in increased neuronal activation (Jin and Gereau, 2006) . Furthermore, the consistent role of MAP kinases and PI 3 K in spinal modulation of hyperalgesic and overt pain-like behavior in inflammatory and neuropathic pain supports their importance in nociceptive processes (Svensson et al., 2003; Ji and Strichartz, 2004; Obata et al., 2004; Jin and Gereau, 2006; Xu et al., 2007; Pezet et al., 2008; Choi et al., 2010; Fitzsimmons et al., 2010; Alter et al., 2010; Carvalho et al., 2011; Zhang et al., 2011) .
Moreover, in the formalin test PI 3 K inhibition diminishes the nociceptive behavior in both phases by mechanisms involving reduced ERK and CaMKII (calcium-calmodulin-dependent protein kinase II) phosphorylation, decreases the phosphorylation of the NMDA receptor subunit NR2B, decreases translocation to the plasma membrane of the GluR1 (glutamate receptor 1) AMPA receptor subunit in the spinal cord as well as reduces evoked neuronal activity as measured using c-Fos immunohistochemistry (Pezet et al., 2008) . This activation of spinal PI 3 K by peripheral formalin injection activates the PI 3 K/Akt/mTOR (mammalian target of rapamicyn) signaling pathway in the spinal cord contributing to neuronal excitability. Colocalization studies using immunofluorescence indicated that formalin activates the PI 3 K/Akt/mTOR signaling pathway in neurons (Xu et al., 2011) . The ERK activation in the formalin test was reported to be relevant in both phases of formalin test similar to the PI 3 K inhibitor results and present data (Pezet et al., 2008; Alter et al., 2010; Xu et al., 2011 and present data) , which is consistent with the PI 3 K-dependent activation of ERK in the formalin test (Pezet et al., 2008) . However, it remains to be shown in which cell or cells ERK is being activated by peripheral formalin stimulus. Nevertheless, it is likely that this ERK activation occurs in the same cell as PI 3 K as shown in other models (Zhuang et al., 2004; Guan et al., 2010) .
JNK inhibitors were reported to inhibit the second phase of formalin test (Li et al., 2010a (Li et al., , 2010b (Li et al., , 2010c and herein it was detected its participation in both phases. It is possible that the difference between strains (Swiss mice versus many mice strains tested except the Swiss strain) and doses of formalin (25 μl of 1.5% formalin versus 20 μl of 5% formalin) might explain these divergent data (present data and Li et al., 2010a Li et al., , 2010b Li et al., , 2010c .
On the other hand, regarding p38, the present results indicate its role in both phases of formalin test as previously described (Hua et al., 2005) . The evidence in the formalin model indicates that p38 is activated in microglia cells since it was inhibited by minocyclin (a broad spectrum tetracycline antibiotic, which inhibits microglia activity- Maier et al., 2007) treatment (Li et al., 2010a (Li et al., , 2010b (Li et al., , 2010c . Furthermore, other nociceptive stimuli such as substance P and carrageenin induce p38 activation in spinal microglia (Li et al., 2010a (Li et al., , 2010b (Li et al., , 2010c . In the present study it was observed that minocyclin and fluocitrate (a specific inhibitor of microglia Krebs cycle- Sun et al., 2008) diminished formalin-, acetic acid-and PBQ-induced overt pain-like behavior suggesting the role of spinal microglia in these responses. Furthermore, p38 can also be activated in astrocytes (Sorkin et al., 2009 ) as well as low levels of p38 phosphorylation were detected in astrocytes and neurons (Li et al., 2010a (Li et al., , 2010b (Li et al., , 2010c .
Although there are many studies on the spinal kinases activated by peripheral injection of formalin in the paw, there is only a partial picture of the mechanisms activated in each cell in the spinal cord or DRG in this model, which was constructed in association with data in the carrageenin-and complete Freund's adjuvant-induced paw inflammation and intrathecal administration of substance P (Svensson et al., 2003; Hua et al., 2005; Alter et al., 2010; Xu et al., 2011) . At the moment, it can be concluded that after formalin injection there is PI 3 K activation in the spinal cord neurons, which seems to be an initial step and is responsible for ERK activation, possibly in neurons (Zhuang et al., 2004; Pezet et al., 2008; Alter et al., 2010; Guan et al., 2010; Xu et al., 2011) . It is unclear in which cell in the spinal cord JNK is activated after formalin injection in the paw while p38 activation occurs mainly in microglia though its activation is also detected, to a lesser extent, in astrocytes and neurons (Sorkin et al., 2009; Li et al., 2010a Li et al., , 2010b Li et al., , 2010c . Taking into account the similar pharmacological susceptibility with kinase and microglia inhibitors in the formalin (Watkins et al., 1997; Hua et al., 2005; Qin et al., 2006; Lan et al., 2006; Sorkin et al., 2009; Li et al., 2010a Li et al., , 2010b Li et al., , 2010c Pezet et al., 2008; Alter et al., 2010; Xu et al., 2011, present data) , acetic acid and PBQ models (present data), it is possible that these peripheral stimuli (e.g. formalin, acetic acid and PBQ) induce flinch and writhing responses by activating similar spinal mechanisms including cells and kinases, which merit further investigation. Corroborating, in a model of visceral pain induced by the intrarectal administration of formalin, there is spinal activation of p38 and cFos expression (Xu et al., 2010) . Thus, visceral administration of formalin can activate similar spinal mechanisms as formalin injection in the paw as well as acetic acid or PBQ intraperitoneal administration seem to activate similar mechanisms to formalin injected in the paw or intrarectal.
Importantly, we have previously shown that none of the intrathecal treatments with kinase inhibitors tested herein alters mechanical hyperalgesia in the contra-lateral paw to G-CSF (granulocyte-colony stimulating factor) stimulus, indicating that PD98059, SB600125, SB202190 and wortmannin do not alter the basal mechanical threshold of normal tissue (Carvalho et al., 2011) . Thus, it is unlikely that these inhibitors would affect the basal visceral response at the doses tested. The MAP kinase and/or PI 3 K inhibitors and microglia inhibitors (minocycline and fluorocitrate) used herein reduced by up to 60% and 35% the acetic acid-and up to 80% and 48% the PBQ-induced writhing response, respectively. It is possible that higher doses of inhibitors could result in abolishment of nociception, however, we refrain to use doses that are higher than those in the literature to avoid losing their selectivity (Watkins et al., 1997; Milligan et al., 2003; Zhuang et al., 2004 Zhuang et al., , 2005 Ledeboer et al., 2005; Hua et al., 2005; Doya et al., 2005; Qin et al., 2006; Lan et al., 2006; Xu et al., 2007; Chen et al., 2009) . The result demonstrating that the combined treatment, at doses that are ineffective as single treatment, abolished acetic acidand PBQ-induced writhing and formalin-induced flinch response suggests a sequential and/or synergic role of spinal p38, ERK, JNK, and PI 3 K in these nociceptive responses. Corroborating a sequential pathway and the interaction of PI 3 K and MAP kinases, PI 3 K activates ERK in primary sensory neurons inducing heat and mechanical hyperalgesia (Zhuang et al., 2004; Guan et al., 2010) and in the spinal cord mediating formalin nociception (Pezet et al., 2008) . MAP kinases present a different interaction among them compared to PI 3 K/MAP kinases relationship since they can act in a co-dependent manner to activate transcription factors such as activating protein-1 (AP-1) as known for JNK and ERK (Kim and Iwao, 2003) . On the other hand, p38, ERK and JNK, in general, do not activate each other. Corroborating, ERK and p38 inhibitors do not affect G-CSF-induced JNK activation in a model of cell proliferation (Rausch and Marshall, 1997) . Thus, the combined treatment with MAP kinases and PI 3 K inhibitors could allow reduced doses of such inhibitors (1 μg of each inhibitor in the writing tests or 0.1 μg of each inhibitor in the formalin test) compared to single drug treatment (10 μg of a single inhibitor).
Peripheral administration of cytokines such as G-CSF and other inflammatory mediators induces mechanical hyperalgesia dependent on spinal MAP kinases and PI 3 K (Carvalho et al., 2011; Guan et al., 2010) . Therefore, it is conceivable that peripheral nociceptive mediators produced in response to acetic acid, PBQ and formalin would be responsible for spinal activation of ERK, JNK, p38 and PI 3 K. In agreement, cytokines such as TNFα and IL-1β which mediate acetic acid writhing response (Ribeiro et al., 2000) and second phase of formalin test (Chichorro et al., 2004) induce neuronal and non-neuronal activation of ERK, JNK, p38 and/or PI 3 K (Ji and Strichartz, 2004; Sung et al., 2005; Davis et al., 2006; Takada et al., 2008; Zhang et al., 2011) . The PBQ stimulus trigger a different peripheral cytokine cascade compared to acetic acid, it induces writhing response dependent on IL-18, IFNγ and endothelin-1 (Verri et al., 2008b) . These mediators also induce ERK, JNK, p38 and/or PI 3 K activation in neuronal and nonneuronal cells (Miyoshi et al., 2008; Seo et al., 2009; Kim et al., 2010; Oyeniran and Tanfin, 2011) . Initially, two models of writing response were used to investigate whether the difference in peripheral mediators would result in different spinal mechanisms, and the formalin test was used because it present some similarities regarding peripheral mediators compared to acetic acid (Ribeiro et al., 2000; Chichorro et al., 2004) and for comparison purposes with previous spinal mechanisms demonstrated in formalin test. However, although (Fig. 6A) , PBQ (Fig. 6B) or formalin (Fig. 6C) stimulus. The vehicle of acetic acid and formalin was saline and PBQ 2% DMSO in saline. The cumulative number of writhing responses induced by acetic acid and PBQ were determined over 20 min and presented at 2 min interval, and the number of flinches induced by formalin were determined over 30 min and presented at 5 min interval. Results are presented as means ± s.e.m. of 6 mice per group, and are representative of 2 separated experiments. *P b 0.05 compared with saline; #P b 0.05 compared with acetic acid, PBQ and formalin (One-way ANOVA followed by Bonferroni's test).
there are some peripheral differences in the mediators released in each model (acetic acid, PBQ and formalin) and the observed behavior (writhing and flinch), the consistent spinal similarities regarding the role of microglia, ERK, JNK, p38 and PI 3 K suggests a common spinal integrative pathway between peripheral and central processing of pain in these models. These mechanisms are also consistent in models of hyperalgesia induced by carrageenan, complete Freund's adjuvant and substance P (Svensson et al., 2003; Pezet et al., 2008; Alter et al., 2010; Xu et al., 2011) . Therefore, demonstrating the importance of these signaling pathways in nociceptive responses and suggesting them as therapeutic targets.
The present study demonstrated, to our knowledge, the first evidence that spinal MAP kinases (ERK, JNK and p38) and PI 3 K, and microglia mediate acetic acid-and PBQ-induced writhing response in mice. It is also important to note the increase effectiveness of cotreatment with kinases inhibitors compared to single kinase inhibitor at ineffective doses to reduce acetic acid, PBQ and formalin overt pain-like behaviors. These results suggest that these fast learning/ performing and low cost models of nociception could also be used to evaluate the activity of MAP kinases, PI 3 K and microglia inhibitors as well as that these mechanisms may also be involved in the action of novel drugs tested in these models. Nevertheless, further colocalization studies and biochemical evidence is necessary to consolidate the present behavioral and pharmacological data.
